Princeton BioMolecular Research is a privately held company established in 1998. We design unique small molecules and develop advanced tools for drug discovery, enabling new generations of chemical entities. Our technology is based on the interdisciplinary expertise of scientists, enhanced knowledge of biological catalysis, and new methodologies from drug, pesticide, and natural product discoveries. We are an experienced and reliable source of compounds for major pharmaceutical and agricultural companies. Our compound libraries are designed to possess drug-like properties. They are created using innovative technologies along with traditional medicinal chemistry principles.